Zexing YANG, Ya WEN, Cunmei SU, Huawei WANG, Meng RAO, Yuhang ZHENG, Limei HE. Comparison the Clinical Outcomes of Progestin-Primed Ovarian Stimulation during Follicular Period and Mild-stimulation in Patients with Diminished Ovarian Reserve[J]. Journal of Kunming Medical University, 2022, 43(12): 53-57. doi: 10.12259/j.issn.2095-610X.S20221211
Citation: Zexing YANG, Ya WEN, Cunmei SU, Huawei WANG, Meng RAO, Yuhang ZHENG, Limei HE. Comparison the Clinical Outcomes of Progestin-Primed Ovarian Stimulation during Follicular Period and Mild-stimulation in Patients with Diminished Ovarian Reserve[J]. Journal of Kunming Medical University, 2022, 43(12): 53-57. doi: 10.12259/j.issn.2095-610X.S20221211

Comparison the Clinical Outcomes of Progestin-Primed Ovarian Stimulation during Follicular Period and Mild-stimulation in Patients with Diminished Ovarian Reserve

doi: 10.12259/j.issn.2095-610X.S20221211
  • Received Date: 2022-05-10
  • Publish Date: 2022-12-25
  •   Objective   To compare the clinical outcomes of PPOS protocal and mild-stimulation protocal in patients with diminished ovarian reserve function during assisted reproduction and pregnancy.   Methods   Patients with DOR who underwent the first and second generation of test-tube babies(IVF/ICSI) in the First Affiliated Hospital of Kunming Medical University from April 2021 to April 2022 were retrospectively analyzed. A total of 294 cycles were included and divided into 2 groups(group A: PPOS group, group B: mild-stimulation group). The medication, embryo status and pregnancy outcomes were compared between the two groups.   Results   Initiation dose of Gn, total Gn dose, HCG dose on trigger day in group A were significantly higher than those in group B(P < 0.05); LH on HCG day in group A was lower than that in group B( P < 0.05). The number of eggs, embryos and high quality embryos in group A were higher than those in group B( P < 0.05).   Conclusion   The clinical outcomes of the PPOS group were better than the mild-stimulation group.
  • [1]
    张婉玉,李静,张凌寒,等. 卵巢储备功能下降的不孕症女性抗苗勒管激素与体重指数的相关性研究[J]. 生殖医学杂志,2021,30(4):441-446. doi: 10.3969/j.issn.1004-3845.2021.04.005
    [2]
    刘亚丽,于莎,陈秋菊,等. 克罗米芬联合高孕激素促排卵抑制早发LH峰的临床结局研究[J]. 生殖与避孕,2016,36(4):263-269.
    [3]
    Chen M,Wu Y,Huang X,et al. Embryo incubation by time-lapse systems versus conventional incubators in Chinese women with diminished ovarian reserve undergoing IVF/ICSI:A study protocol for a randomised controlled trial[J]. BMJ Open,2020,10(11):038657.
    [4]
    Pelosi E,Simonsick E,Forabosco A,et al. Dynamics of the ovarian reserve and impact of genetic and epidemiological factors on age of menopause[J]. Biol Reprod,2015,92(5):130.
    [5]
    Greenead,Patounakis G,Segars J H. Genetic associations with diminished ovarian reserve:A systematic review of the literature[J]. J Assist Reprod Genet,2014,31(8):935-946. doi: 10.1007/s10815-014-0257-5
    [6]
    Yu R,Jin H,Huang X F,et al. Comparison of modified agonist,mild-stimulation and antagonist protocols for in vitro fertilization in patients with diminished ovarian reserve[J]. J Int Med Res,2018,46(6):2327-2337. doi: 10.1177/0300060518770346
    [7]
    Kuang Y,chen Q,FU Y,et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization[J]. Fertil Steril,2015,104(1):62-70.e3. doi: 10.1016/j.fertnstert.2015.03.022
    [8]
    Wang Y,Kuang Y,Chen Q,et al. Gonadotropin-releasing hormone antagonist versus progestin for the prevention of premature luteinising hormone surges in poor responders undergoing in vitro fertilisation treatment:Study protocol for a randomised controlled trial[J]. Trials,2018,19(1):455. doi: 10.1186/s13063-018-2850-x
    [9]
    刘洋,南燕,陈帆,等. 不同促排卵方案在高龄卵巢储备功能减退患者中的应用效果比较[J]. 新乡医学院学报,2020,37(5):465-470.
    [10]
    曾倩凌,燕怡,李艳萍,等. 高孕激素状态下促排卵与微刺激方案在卵巢储备功能下降患者中的临床结局及经济效益比较[J]. 中国临床研究,2020,33(7):908-912. doi: 10.13429/j.cnki.cjcr.2020.07.010
    [11]
    Ubaldi F M,Cimadomo D,Vaiarelli A,et al. Advanced maternal age in IVF:Still a challenge? The present and the future of its treatment[J]. Front Endocrinol (Lausanne),2019,20(10):94.
    [12]
    Drakopoulos P, Bardhi E, Boudry L, et al. Update on the management of poor ovarian response in IVF: The shift from Bologna criteria to the Poseidon concept[J]. Ther Adv Reprod Health, 2020 , 31(14): 2633494120941480.
    [13]
    Liu X,Li T,Wang B,et al. Mild stimulation protocol vs conventional controlled ovarian stimulation protocol in poor ovarian response patients:A prospective randomized controlled trial[J]. Arch Gynecol Obstet,2020,301(5):1331-1339. doi: 10.1007/s00404-020-05513-6
    [14]
    Casano S,Guidetti D,Patriarca A,et al. MILD ovarian stimulation with GnRH-antagonist vs. long protocol with low dose FSH for non-PCO high responders undergoing IVF:A prospective,randomized study including thawing cycles[J]. J Assist Reprod Genet,2012,29(12):1343-1351. doi: 10.1007/s10815-012-9863-2
    [15]
    沈秀,李颂军,周睿琼,等. 高孕激素下促排卵方案用于 FSH 升高DOR患者的临床效果观察[J]. 生殖医学杂志,2017,26(4):351-356. doi: 10.3969/j.issn.1004-3845.2017.04.012
    [16]
    中华医学会妇产科学分会绝经学组. 早发性卵巢功能不全的激素补充治疗的专家共识[J]. 中华妇产科杂志,2016,51(12):881-886.
    [17]
    Li X,Zhang X,Cai J,et al. Granulosa cells apoptosis and follicular fluid hormones:Comparison of progestin-primed ovarian stimulation versus GnRH antagonist protocols[J]. Gynecol Endocrinol,2021,37(7):609-613. doi: 10.1080/09513590.2020.1822802
    [18]
    温国亮. 不孕症患者冷冻胚胎移植后妊娠结局的影响因素[J]. 当代医学杂志,2022,28(21):129-131.
    [19]
    Salehnia M,Zavareh S. The effects of progesterone on oocyte maturation and embryo development[J]. Int J Fertil Steril,2013,7(2):74-81.
  • Relative Articles

    [1] Fen TENG, Bo TIAN, Chongxi LI, Yongmei JIN, Haiyun CHEN, Jun LIU. Real-World Clinical Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide (BIC/FTC/TAF) Single-Tablet Regimen. Journal of Kunming Medical University, 2024, 45(4): 74-80.  doi: 10.12259/j.issn.2095-610X.S20240411
    [2] Chenxi LI, Zhuocen ZHA, Na LI, Lin LUO, Yang YANG, Wenlin CHEN. Selection of Intensive Adjuvant Therapy for Triple-positive Breast Cancer. Journal of Kunming Medical University, 2023, 44(10): 180-188.  doi: 10.12259/j.issn.2095-610X.S20231020
    [3] Bo TIAN, Chongxi LI, Yongmei JIN, Wei GUAN, Haiyun CHEN, Jun LIU. Use and Replacement of Treatment Regimens for AIDS Patients on Antiretroviral Therapy. Journal of Kunming Medical University, 2023, 44(5): 162-167.  doi: 10.12259/j.issn.2095-610X.S20230508
    [4] Jiang ZHANG, Xi-juan ZHAO, Jiang WU, Yan LIU, Li-juan LI, Ye CHEN. Application of Family Empowerment Nursing Intervention Program in Patients with Lung Cancer Undergoing Radiotherapy. Journal of Kunming Medical University, 2021, 42(12): 169-176.  doi: 10.12259/j.issn.2095-610X.S20211242
    [5] Li Li Ping , Zhao Hong Chao , Zhang Yun Zhu , Li Jun . . Journal of Kunming Medical University, 2019, 40(08): 47-51.
    [6] Zhang Wen . The Clinical Analysis of Three Kinds of Treatment Regimens for 300 Cases of Bacterial Vaginal Disease. Journal of Kunming Medical University,
    [7] Xu Hui Ling . . Journal of Kunming Medical University,
    [8] Shan Da Yan . . Journal of Kunming Medical University,
    [9] Zhang Ming . . Journal of Kunming Medical University,
    [10] Guo Pei Yu . . Journal of Kunming Medical University,
    [11] Wan Yun Yan . . Journal of Kunming Medical University,
    [12] Zhou Jiu Peng . . Journal of Kunming Medical University,
    [13] Yue Cheng Shan . . Journal of Kunming Medical University,
    [14] Wang Jue . . Journal of Kunming Medical University,
    [15] Li Dong Ya . . Journal of Kunming Medical University,
    [16] Zhang Ren Fa . . Journal of Kunming Medical University,
    [17] Yang Ai Ling . . Journal of Kunming Medical University,
    [18] . Clinical Study of Kangai Injection Combined with FORFIRI Chemotherapy in the Treatment of 30 Cases of Advanced Colon Cancer. Journal of Kunming Medical University,
    [19] . Investigating Optimal Types of Iatrogenic Bile Duct Injury——A Retrospective Analysis of Clinical Treatment With 52 Cases. Journal of Kunming Medical University,
    [20] Chen Shi Ling . . Journal of Kunming Medical University,
  • Cited by

    Periodical cited type(2)

    1. 张淑芝,夏海武,高明刚. 水通道蛋白8原核表达载体的构建及其表达纯化. 畜牧与兽医. 2018(11): 55-59 .
    2. 张淑芝,李学红,刘春香. GST融合蛋白表达系统在实验教学中的应用. 实验室研究与探索. 2018(11): 194-197 .

    Other cited types(1)

  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-040
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 26.6 %FULLTEXT: 26.6 %META: 73.3 %META: 73.3 %PDF: 0.1 %PDF: 0.1 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution其他: 5.0 %其他: 5.0 %China: 4.2 %China: 4.2 %上海: 6.7 %上海: 6.7 %东莞: 0.1 %东莞: 0.1 %丽水: 0.0 %丽水: 0.0 %佛山: 0.1 %佛山: 0.1 %北京: 20.2 %北京: 20.2 %南阳: 0.1 %南阳: 0.1 %台州: 0.4 %台州: 0.4 %天津: 0.0 %天津: 0.0 %巴黎: 0.0 %巴黎: 0.0 %张家口: 0.1 %张家口: 0.1 %杭州: 0.1 %杭州: 0.1 %氹仔: 0.0 %氹仔: 0.0 %湖州: 0.2 %湖州: 0.2 %芒廷维尤: 0.7 %芒廷维尤: 0.7 %衢州: 0.2 %衢州: 0.2 %西宁: 2.5 %西宁: 2.5 %许昌: 0.0 %许昌: 0.0 %连云港: 0.0 %连云港: 0.0 %郑州: 0.8 %郑州: 0.8 %金华: 0.1 %金华: 0.1 %驻马店: 58.2 %驻马店: 58.2 %其他China上海东莞丽水佛山北京南阳台州天津巴黎张家口杭州氹仔湖州芒廷维尤衢州西宁许昌连云港郑州金华驻马店

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(3)

    Article Metrics

    Article views (3256) PDF downloads(13) Cited by(3)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return